Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hoth Therapeutics Inc HOTH

Healthcare
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s... see more

Recent & Breaking News (NDAQ:HOTH)

Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma

PR Newswire December 9, 2019

Hoth Therapeutics to Present at the LD Micro Main Event (XII)

Accesswire December 2, 2019

Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy

PR Newswire November 26, 2019

Hoth Therapeutics to Attend Benchmark's 8th Annual Discovery 1x1 Conference

PR Newswire November 18, 2019

Hoth Therapeutics Initiates Preclinical Study Including Topical Form of Aprepitant for Dermatological Treatment Relating to Side Effects of Cancer Medication

PR Newswire November 14, 2019

Hoth Therapeutics Initiates Confirmatory Study for Lupus Treatment

PR Newswire November 6, 2019

Four Innovators Targeting Multi-Billion-Dollar Market Opportunities in: E-Commerce, Healthcare Augmented Reality, and Cannabis

GlobeNewswire October 16, 2019

Hoth Therapeutics to Present at the Dawson James 5th Annual Small Cap Growth Conference

PR Newswire October 15, 2019

Hoth Therapeutics Makes Donation to National Eczema Association in Sponsorship of "National Eczema Awareness Month"

PR Newswire October 14, 2019

Hoth Therapeutics Successfully Completes Phase I of In-Life Dose Escalation Study for Treating Eczema

PR Newswire October 8, 2019

Wall Street Reporter presents: "NEXT SUPER STOCK - Live!" Investor Conference September 26, 2019

GlobeNewswire September 25, 2019

Emerging Markets Report: Looking Beyond Skin Deep

GlobeNewswire September 25, 2019

Hoth Therapeutics, Inc. to Present at Diamond Equity Research Emerging Growth Invitational

PR Newswire September 24, 2019

New Ideas for Billion Dollar Markets: Emerging Leaders in Cannabis, Augmented Reality, and Healthcare

GlobeNewswire September 18, 2019

Next Super Stock conference presenters: CYDY, MDCL, HOTH, NEXCF delivering results, and positioned for transformational growth in coming months

GlobeNewswire September 16, 2019

Diamond Equity Research Initiates Coverage on Hoth Therapeutics, Inc. (NASDAQ: HOTH)

ACCESSWIRE IA September 16, 2019

Hoth Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference

PR Newswire September 6, 2019

Hoth Therapeutics, Inc. Issues Letter to Shareholders

PR Newswire September 4, 2019

Hoth Therapeutics and Zylö Therapeutics Finalize Agreement

PR Newswire August 21, 2019

Hoth Therapeutics, Inc. Announces Positive Results from Pilot Study of BioLexa on Diabetic Skin Ulcers

PR Newswire July 22, 2019